Oct 13 (Reuters) - Danish obesity-drug developer Zealand Pharma has partnered with US biotechnology company Generate ...

ZURICH, Oct 13 (Reuters) - Swiss drugmaker Roche entered a licensing agreement worth up to $1.16 billion with Rona ...

A new global definition of clinical obesity classifies far fewer children as obese than widely used body mass index (BMI) ...

Researchers published late-stage clinical trial data today for the latest obesity drug, retatrutide—expected to be the most powerful formula yet—and the results appear in line with high expectations.

Murdoch Children's Research Insitute pediatrician Dr. Danielle Longmore discusses a new global childhood obesity definition ...

A new global definition of clinical obesity classifies far fewer children as obese than the widely used body mass index (BMI) ...

An alliance with Rona Therapeutics adds to a particularly active stretch for Roche and makes the company the latest to bet on ...

Thanks to new research, we’re learning more about a twist in the relationship between body weight and cancer survival that ...

The World Health Organization (WHO) released new recommendations for fighting childhood obesity, and at least one puts its ...

Louisiana jumped in the rankings for adult obesity rates, from the fourth-highest rate in the nation in 2023 to 19th-highest ...

Middle East governments are ramping up measures in a new war, as rising obesity rates threaten public health. But can these ...

Zealand Pharma partners with Generate Biomedicines in an AI-driven obesity drug deal worth up to $1.2 billion in milestones ...